We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$15M
AUM Growth
-$170M
Cap. Flow
-$69.6M
Cap. Flow %
-462.87%
Top 10 Hldgs %
51.84%
Holding
132
New
31
Increased
18
Reduced
10
Closed
70

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.45M
2
IHI icon
iShares US Medical Devices ETF
IHI
+$875K
3
RDCM icon
Radcom
RDCM
+$577K
4
APLS
Apellis Pharmaceuticals
APLS
+$491K
5
INSM icon
Insmed
INSM
+$431K

Top Sells

Rank Stock Value
1
MYO icon
Myomo
MYO
+$7M
2
ASPN icon
Aspen Aerogels
ASPN
+$6.96M
3
INDI icon
indie Semiconductor
INDI
+$4.63M
4
SCPH
scPharmaceuticals
SCPH
+$4.31M
5
TGAN
Transphorm, Inc. Common Stock
TGAN
+$4.21M

Sector Composition

Rank Sector Weight
1 Healthcare 29.82%
2 Technology 27.27%
3 Real Estate 20.31%
4 Communication Services 5.72%
5 Consumer Staples 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DFSC
101
DEFSEC Technologies
DFSC
$3.55M
– –
-1,351
Closed -$255K
DFSCW
102
DEFSEC Technologies Warrant
DFSCW
– –
-282,092
Closed -$25.8K
LPSN icon
103
LivePerson
LPSN
$27.7M
– –
-26,714
Closed -$1.52M
LPTH icon
104
Lightpath Technologies
LPTH
$787M
– –
-929,611
Closed -$1.17M
LUV icon
105
Southwest Airlines
LUV
$24B
– –
-19,433
Closed -$561K
LUV icon
106
PUT
Southwest Airlines
LUV
$24B
– –
-41,000
Closed -$1.81K
MCHP icon
107
Microchip Technology
MCHP
$43.6B
– –
-13,180
Closed -$1.19M
MYO icon
108
Myomo
MYO
$42.5M
– –
-1,397,861
Closed -$7M
OEF icon
109
PUT
iShares S&P 100 ETF
OEF
$20.5B
– –
-11,400
Closed -$570
OMF icon
110
OneMain Financial
OMF
$7.54B
– –
-48,433
Closed -$2.38M
OUST icon
111
Ouster
OUST
$3.17B
– –
-469,312
Closed -$3.6M
PGR icon
112
Progressive
PGR
$122B
– –
-14,120
Closed -$2.25M
PROF
113
Profound Medical
PROF
$309M
– –
-160,971
Closed -$1.37M
RCAT icon
114
Red Cat Holdings
RCAT
$1.36B
– –
-1,250,997
Closed -$1.1M
RJF icon
115
Raymond James Financial
RJF
$34.3B
– –
-12,660
Closed -$1.41M
SIGA icon
116
CALL
SIGA Technologies
SIGA
$236M
– –
-75,500
Closed -$7.55K
SILC icon
117
Silicom
SILC
$264M
– –
-40,810
Closed -$739K
SRPT icon
118
Sarepta Therapeutics
SRPT
$1.7B
– –
-5,400
Closed -$661K
SRPT icon
119
PUT
Sarepta Therapeutics
SRPT
$1.7B
– –
-49,800
Closed -$55.3K
SVREW
120
SaverOne 2014 Ltd Warrant
SVREW
– –
-140,864
Closed -$16.9K
THTX
121
DELISTED
Theratechnologies
THTX
– –
-906,557
Closed -$1.47M
TNDM icon
122
PUT
Tandem Diabetes Care
TNDM
$1.39B
– –
-62,400
Closed -$9.36K
TYL icon
123
Tyler Technologies
TYL
$12.6B
– –
-1,666
Closed -$697K
VERU icon
124
Veru
VERU
$37.7M
– –
-85,586
Closed -$616K
VRNA
125
PUT
DELISTED
Verona Pharma
VRNA
– –
-15,200
Closed -$5.7K
2 3 4
5
6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Worth Venture Partners held 132 positions worth $15M, down 92% from $185M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Worth Venture Partners withdrew a net $69.6M in Q1 2024, closing 70 positions and reducing 10 holdings. Its most notable exit was Myomo, an estimated $7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 21% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Worth Venture Partners opened a new position in Johnson & Johnson worth $1.44M.

  • Worth Venture Partners's largest Q1 2024 buy was Johnson & Johnson: 9,100 shares worth $1.44M.
  • Worth Venture Partners added most to Arteris in Q1 2024, an estimated $185K increase.
  • Worth Venture Partners's biggest Q1 2024 reduction was scPharmaceuticals, cutting an estimated $4.31M.
  • Worth Venture Partners fully exited Myomo in Q1 2024, selling an estimated $7M.
  • Worth Venture Partners's ten largest holdings make up 52% of its $15M portfolio in Q1 2024.
  • Worth Venture Partners opened 31 new positions and closed 70 in Q1 2024.
  • Worth Venture Partners's portfolio value fell 92% quarter-over-quarter to $15M.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.